In this study, 47.6% of glioma patients were detected ctDNA including 1p/19q, MDM2, ERBB2, IDH1, CDKN2A, CDK4, PDGFRA, CCNE1, MET. This evidence concerns the gene CDK4 and central nervous system cancer.